Filing Details
- Accession Number:
- 0001179110-10-003133
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-02-18 12:00:00
- Reporting Period:
- 2010-02-16
- Filing Date:
- 2010-02-18
- Accepted Time:
- 2010-02-18 18:08:25
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1800 | Abbott Laboratories | ABT | Pharmaceutical Preparations (2834) | 360698440 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1360215 | Olivier Bohuon | 100 Abbott Park Road Abbott Park IL 60064-6400 | Executive Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares Without Par Value | Acquisiton | 2010-02-16 | 17,000 | $0.00 | 90,676 | No | 4 | A | Direct | |
Common Shares Without Par Value | Disposition | 2010-02-16 | 2,300 | $54.39 | 88,376 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2010-02-16 | 100 | $54.39 | 88,276 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2010-02-16 | 6,100 | $54.39 | 82,176 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- Settlement of a performance-based restricted stock unit in shares in a transaction exempt from Section 16(b) under Rule 16b-3.